Premium
Clinical evaluation of the newly formatted lateral‐flow device for invasive pulmonary aspergillosis
Author(s) -
Hoenigl Martin,
Eigl Susanne,
Heldt Sven,
Duettmann Wiebke,
Thornton Christopher,
Prattes Juergen
Publication year - 2018
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12704
Subject(s) - pulmonary aspergillosis , aspergillosis , medicine , aspergillus , diagnostic accuracy , microbiology and biotechnology , biology , immunology
Summary The study evaluated the newly formatted Aspergillus ‐specific lateral‐flow‐device ( LFD ), and compared its performance to the original prototype “old” LFD test using BALF samples from 28 patients (14 patients with probable/proven invasive pulmonary aspergillosis [ IPA ] and 14 patients with no evidence for IPA ). A total of 10/14 (71%) of BALF samples from patients with probable/proven IPA resulted positive with the new LFD , including 8/9 with true‐positive and 2/5 with false‐negative results with the old LFD . All 14 samples from patients without IPA resulted negative with the new LFD ; specificity of the new LFD was significantly improved compared to the old LFD .